Literature DB >> 28249309

Iodinated Contrast Media and the Alleged "Iodine Allergy": An Inexact Diagnosis Leading to Inferior Radiologic Management and Adverse Drug Reactions.

Ingrid Böhm1, Knud Nairz1, John N Morelli2, Patricia Silva Hasembank Keller1, Johannes T Heverhagen1.   

Abstract

Purpose To test the hypothesis that the incomplete diagnosis "iodine allergy" is a possibly dangerous concept for patients under routine radiologic conditions. Materials and Methods 300 patients with a history of an "iodine allergy" were retrospectively screened and compared with two age-, sex-, and procedure-matched groups of patients either diagnosed with a nonspecific "iodine contrast medium (ICM) allergy" or an allergy to a specific ICM agent. For all groups, the clinical symptoms of the most recent past adverse drug reaction (ADR), prophylactic actions taken for subsequent imaging, and ultimate outcome were recorded and analyzed. Results The diagnosis "iodine allergy" was not otherwise specified in 84.3 % patients. For this group, in most cases, the symptoms of the previous ADRs were not documented. In contrast, the type of ADR was undocumented in only a minority of patients in the comparison groups. In the group of patients with an "iodine allergy" the percentage of unenhanced CT scans was greater than within the other two groups (36.7 % vs. 28.7 %/18.6 %). ADRs following prophylactic measures were only observed in the "iodine allergy" group (OR of 9.24 95 % CI 1.16 - 73.45; p < 0.04). Conclusion This data confirms the hypothesis that the diagnosis "iodine allergy" is potentially dangerous and results in uncertainty in clinical management and sometimes even ineffective prophylactic measures. Key points  · The term "iodine allergy" is imprecise, because it designates allergies against different substance classes, such as disinfectants with complexed iodine and contrast media containing covalently bound iodine.. · There is a clear correlation between the exactness of the diagnosis - from the alleged "iodine allergy" to "contrast media allergy" to naming the exact culprit CM - and the quality of documentation of the symptoms.. · Management of patients diagnosed with "iodine allergy" was associated with uncertainty leading to unenhanced scans and sometimes unnecessary prophylactic actions.. · The term "iodine allergy" should be omitted, because it is potentially dangerous and can decrease the quality of radiology exams.. Citation Format · Böhm Ingrid, Nairz Knud, Morelli John N et al. Iodinated Contrast Media and the Alleged "Iodine Allergy": An Inexact Diagnosis Leading to Inferior Radiologic Management and Adverse Drug Reactions. Fortschr Röntgenstr 2017; 189: 326 - 332. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28249309     DOI: 10.1055/s-0042-122148

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  5 in total

1.  Coronary CT Angiography Using Low Iodine Delivery Rate and Tube Voltage Determined by Body Mass Index: Superiority in Clinical Practice.

Authors:  Wang Yuan; Ting-Ting Qu; Hui-Juan Wang; Mei-Yu Wang; Yuan Qu; Gang Niu; Jian Yang
Journal:  Curr Med Sci       Date:  2019-10-14

Review 2.  Current Epidemiology and Management of Radiocontrast-Associated Acute- and Delayed-Onset Hypersensitivity: A Review of the Literature.

Authors:  Eric M Macy
Journal:  Perm J       Date:  2018

3.  30 years of Katayama's article on ionic and non-ionic contrast media: appreciation of well and less known facts of a milestone paper.

Authors:  Ingrid B Böhm
Journal:  Quant Imaging Med Surg       Date:  2020-12

4.  Cross-reactivity among iodinated contrast agents: should we be concerned?

Authors:  Adrian A Schmid; John N Morelli; Martin N Hungerbühler; Ingrid B Boehm
Journal:  Quant Imaging Med Surg       Date:  2021-09

5.  To crack a nut with a sledgehammer: premedication in a patient with a history of mild symptoms following the injection of a contrast agent.

Authors:  Ingrid B Boehm
Journal:  Quant Imaging Med Surg       Date:  2022-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.